Status:
COMPLETED
Efficacy and Safety of Chungkookjang on Improvement of Metabolic Syndrome
Lead Sponsor:
Chonbuk National University Hospital
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-29 years
Phase:
PHASE2
PHASE3
Brief Summary
The investigators performed a 12-week, randomized, double-blind, placebo-controlled crossover human trial to evaluate the efficacy and safety of chungkookjang on improvement of metabolic syndrome. The...
Eligibility Criteria
Inclusion
- Males and females 18-29 years old
- BMI(body mass index) ≥ 23 kg/m2 or WC(Waist Circumference) ≥ 90(men), WC(Waist Circumference) ≥ 85(women)
- Able to give informed consent
Exclusion
- Allergic or hypersensitive to any of the ingredients in the test products
- The diagnosis of type 1 and type 2 diabetes or fasting glucose ≥ 126mg/dL
- Systolic pressure ≥ 160mmHg, diastolic pressure ≥ 100mmHg
- History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- History of alcohol or substance abuse
- Participation in any other clinical trials within past 2 months
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01811511
Start Date
March 1 2013
End Date
February 1 2014
Last Update
February 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obesity Research Center of Chonbuk National University
Jeonju, Jeollabuk-do, South Korea, 560-822